Old Web
English
Sign In
Acemap
>
Paper
>
Daratumumab for disabling cold agglutinin disease refractory to B-cell directed therapy.
Daratumumab for disabling cold agglutinin disease refractory to B-cell directed therapy.
2020
Oliver Tomkins
Sigbjørn Berentsen
Suzanne Arulogun
Mallika Sekhar
Shirley DSa
Keywords:
Daratumumab
Immunology
Diabetes mellitus
Medicine
Refractory
Cold agglutinin disease
B cell
Correction
Source
Cite
Save
Machine Reading By IdeaReader
5
References
3
Citations
NaN
KQI
[]